Amgen bought ChemoCentryx ChemoCentryx from 10/20/22

User image

Vladimir Petenev

News editor
press@blackterminal.com

Amgen completed its acquisition of ChemoCentryx for $3.7 billion, or $52 per share.

ChemoCentryx

Review

Source:

{source} pictogram

investors.amgen.com

Vladimir Petenev

News editor

Write your comment first

News feed

Nornickel completes repairs at Nadezhda Metallurgical Plant

7/12/24 GMKN

Fesco increased exports of agricultural products by 75%

7/12/24 FESH

Tatneft enters the oldest field in Azerbaijan

7/12/24 TATN

MTS Bank's profit in January-May increased by 43%

7/12/24 MBNK

Bank Saint-Petersburg reported for 6 months of 2024 by RAS

7/12/24 BSPB

Ozon launches sale of light-engine airplanes

7/12/24 OZON

Sistema reported for 3 months of 2024 by IFRS

7/12/24 AFKS

Promomed's IPO went over the top

7/12/24 PRMD

Samolet Plus is valued at ₽20 billion

7/11/24 OTCI

Samolet Plus is valued at ₽20 billion

7/11/24 SMLT